Edaño, Eufemia P.

HRN: 22-49-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2023
CEFTRIAXONE 1G (VIAL)
02/01/2023
02/08/2023
IV
2g
OD
NON HEALING WOUND
Waiting Final Action 
02/02/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/02/2023
02/09/2023
IV
600
Q8hrs
Non Healing Wound
Waiting Final Action 
02/02/2023
CEFTAZIDIME 1GM (VIAL)
02/02/2023
02/09/2023
IV
1g
OD
Nonhealing Wound
Waiting Final Action 
02/03/2023
AZITHROMYCIN 500MG TABLET (TAB)
02/03/2023
02/07/2023
ORAL
500
OD
CAP
Waiting Final Action 
02/05/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/05/2023
02/12/2023
IV
1.5g
Q8
DM Foot
Waiting Final Action 
05/29/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2023
06/05/2023
IV
600mg
Q8hrs
CAP-MR
Checking Final Appropriateness 
05/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/30/2023
06/06/2023
IV
1.5gram
Q8hrs
CAP-MR
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: